{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:25:39Z","timestamp":1792599939113,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009162","name":"Universidade Estadual De Londrina","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009162","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Prostate cancer (PCa) remains a highly prevalent malignancy and a leading cause of cancer-related mortality, frequently attributed to late-stage diagnosis. Matrix metalloproteinase 14 (MMP14) and Decorin (DCN) are key extracellular matrix (ECM) components essential for tissue remodeling and tumor suppression. This study evaluated the immunohistochemical expression of MMP14 and DCN in relation to clinicopathological parameters in PCa tissue samples (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200992), specifically examining the malignant epithelium, adjacent non-tumor tissue, and peritumoral stroma. High MMP14 expression in tumor cells was predominant in metastatic patients and significantly associated with the presence of metastases (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.012), with overexpression observed in 60% of these cases. Conversely, diminished DCN staining in the peritumoral ECM was linked to metastatic disease (63% low expression). Furthermore, a significant correlation was identified between low stromal DCN expression and ISUP grades 4\u20135 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.047; 66% of high-grade cases). Multivariate analysis confirmed that MMP14 expression profile serves as an independent predictor of metastasis (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.01). In conclusion, our findings suggest that ECM remodeling, driven by dysregulation of MMP14 and DCN, plays a pivotal role in PCa progression, highlighting their potential as prognostic biomarkers for patient stratification and therapeutic guidance.\n                  <\/jats:p>","DOI":"10.1007\/s10735-026-10869-1","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:17:10Z","timestamp":1782407830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["High MMP14 and low decorin expression correlate with disease progression and metastasis in Brazilian prostate cancer patients"],"prefix":"10.1007","volume":"57","author":[{"given":"Amanda L.","family":"Francelino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Terzioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glauco A. F.","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phelipe Oliveira","family":"Favaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 L. L.","family":"Vanzela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alda F. M. L.","family":"Guembarovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Miqueloto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen B.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6291-8621","authenticated-orcid":false,"given":"Roberta L.","family":"Guembarovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"10869_CR1","unstructured":"American Cancer Society key statistics for prostate cancer | Prostate cancer facts https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/about\/key-statistics.html. Accessed 17 Oct 2025a"},{"key":"10869_CR2","unstructured":"American Cancer Society prostate cancer screening tests https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/detection-diagnosis-staging\/tests.html. Accessed 17 Oct 2025b"},{"key":"10869_CR3","doi-asserted-by":"publisher","first-page":"e210006","DOI":"10.1590\/1980-549720210006","volume":"24","author":"SFM Braga","year":"2021","unstructured":"Braga SFM, Silva RP, da, Guerra Junior AA, Cherchiglia ML (2021) Prostate cancer survival and mortality according to a 13-year retrospective cohort study in Brazil: competing-risk analysis. Rev bras epidemiol 24:e210006. https:\/\/doi.org\/10.1590\/1980-549720210006","journal-title":"Rev bras epidemiol"},{"key":"10869_CR4","doi-asserted-by":"crossref","unstructured":"Brierley JD, Asamura H, Eycken EV, Rous B (2021) TNM atlas. Wiley","DOI":"10.1002\/9781119263906"},{"key":"10869_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1053\/hp.2000.6698","volume":"31","author":"L Bubendorf","year":"2000","unstructured":"Bubendorf L, SCHOPFER A, WAGNER U et al (2000) Metastatic patterns of prostate cancer: an autopsy study of 1589 patients. Hum Pathol 31:578\u2013583. https:\/\/doi.org\/10.1053\/hp.2000.6698","journal-title":"Hum Pathol"},{"key":"10869_CR6","doi-asserted-by":"publisher","first-page":"e29760","DOI":"10.1097\/MD.0000000000029760","volume":"101","author":"H Chen","year":"2022","unstructured":"Chen H, Wang Z, Yang N et al (2022) Decorin inhibits proliferation and metastasis in human bladder cancer cells by upregulating P21. Medicine 101:e29760. https:\/\/doi.org\/10.1097\/MD.0000000000029760","journal-title":"Medicine"},{"key":"10869_CR32","doi-asserted-by":"publisher","unstructured":"de Souza RS, Pinhal MA (2011) da S Intera\u00e7\u00f5es em processos fisiol\u00f3gicos: a import\u00e2ncia da din\u00e2mica entre matriz extracelular e proteoglicanos. Arq Bras Ci\u00eancias Da Sa\u00fade. https:\/\/doi.org\/10.7322\/abcs.v36i1.75","DOI":"10.7322\/abcs.v36i1.75"},{"issue":"4","key":"10869_CR7","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1158\/0008-5472.CAN-08-3255","volume":"69","author":"L Devy","year":"2009","unstructured":"Devy L et al (2009) Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Res 69(4):1515\u20131523","journal-title":"Cancer Res"},{"key":"10869_CR8","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1186\/s12967-024-05564-2","volume":"22","author":"E Di Carlo","year":"2024","unstructured":"Di Carlo E, Sorrentino C (2024) The multifaceted role of the stroma in the healthy prostate and prostate cancer. J Transl Med 22:825. https:\/\/doi.org\/10.1186\/s12967-024-05564-2","journal-title":"J Transl Med"},{"key":"10869_CR9","doi-asserted-by":"publisher","unstructured":"Diehl V, Huber LS, Trebicka J et al (2021) The role of decorin and biglycan signaling in tumorigenesis. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.801801","DOI":"10.3389\/fonc.2021.801801"},{"key":"10869_CR10","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.7150\/ijms.46780","volume":"17","author":"X Geng","year":"2020","unstructured":"Geng X, Chen C, Huang Y, Hou J (2020) The prognostic value and potential mechanism of matrix metalloproteinases among prostate cancer. Int J Med Sci 17:1550\u20131560. https:\/\/doi.org\/10.7150\/ijms.46780","journal-title":"Int J Med Sci"},{"key":"10869_CR11","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1593\/neo.09760","volume":"11","author":"Y Hu","year":"2009","unstructured":"Hu Y, Sun H, Owens RT et al (2009) Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways. Neoplasia 11:1042\u20131053. https:\/\/doi.org\/10.1593\/neo.09760","journal-title":"Neoplasia"},{"issue":"31","key":"10869_CR12","doi-asserted-by":"crossref","first-page":"27581","DOI":"10.1074\/jbc.C200237200","volume":"277","author":"RV Iozzo","year":"2002","unstructured":"Iozzo RV (2002) Biological functions of the small leucine-rich proteoglycans: from genetics to modulate tumor growth. J Biol Chem 277(31):27581\u201327584","journal-title":"J Biol Chem"},{"key":"10869_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2018.03.023","volume":"71\u201372","author":"RV Iozzo","year":"2018","unstructured":"Iozzo RV, Gubbiotti MA (2018) Extracellular matrix: the driving force of mammalian diseases. Matrix Biol 71\u201372:1\u20139. https:\/\/doi.org\/10.1016\/j.matbio.2018.03.023","journal-title":"Matrix Biol"},{"key":"10869_CR14","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.jid.2021.12.016","volume":"142","author":"M K\u00fcmper","year":"2022","unstructured":"K\u00fcmper M, Hessenthaler S, Zamek J et al (2022) Loss of endothelial cell matrix metalloproteinase 14 reduces melanoma growth and metastasis by increasing tumor vessel stability. J Invest Dermatol 142:1923\u20131933e5. https:\/\/doi.org\/10.1016\/j.jid.2021.12.016","journal-title":"J Invest Dermatol"},{"key":"10869_CR15","doi-asserted-by":"publisher","unstructured":"Li M, Li S, Zhou L et al (2021) Immune infiltration of MMP14 in pan cancer and its prognostic effect on tumors. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.717606","DOI":"10.3389\/fonc.2021.717606"},{"key":"10869_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.urolonc.2009.01.026","volume":"27","author":"DW Lin","year":"2009","unstructured":"Lin DW (2009) Beyond PSA: utility of novel tumor markers in the setting of elevated PSA. Urol Oncol Semin Orig Investig 27:315\u2013321. https:\/\/doi.org\/10.1016\/j.urolonc.2009.01.026","journal-title":"Urologic Oncology: Seminars Original Investigations"},{"key":"10869_CR17","doi-asserted-by":"publisher","unstructured":"Liu Y, Xin Y, Lv T et al (2024) Decorin impeded the advancement of thyroid papillary carcinoma by thwarting the EGFR\/ FER\/ SHP2 signaling-induced sustenance of early endosomes. Heliyon https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33358","DOI":"10.1016\/j.heliyon.2024.e33358"},{"key":"10869_CR18","doi-asserted-by":"publisher","unstructured":"Makutani Y, Kawakami H, Tsujikawa T et al (2022) Contribution of MMP14-expressing cancer-associated fibroblasts in the tumor immune microenvironment to progression of colorectal cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.956270","DOI":"10.3389\/fonc.2022.956270"},{"key":"10869_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2020.10.001","volume":"95","author":"L Mao","year":"2021","unstructured":"Mao L, Yang J, Yue J et al (2021) Decorin deficiency promotes epithelial-mesenchymal transition and colon cancer metastasis. Matrix Biol 95:1\u201314. https:\/\/doi.org\/10.1016\/j.matbio.2020.10.001","journal-title":"Matrix Biol"},{"key":"10869_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/j.semdp.2024.05.001","volume":"41","author":"DY Mebratie","year":"2024","unstructured":"Mebratie DY, Dagnaw GG (2024) Review of immunohistochemistry techniques: applications, current status, and future perspectives. Semin Diagn Pathol 41:154\u2013160. https:\/\/doi.org\/10.1053\/j.semdp.2024.05.001","journal-title":"Semin Diagn Pathol"},{"key":"10869_CR21","doi-asserted-by":"publisher","unstructured":"Mondal DK, Xie C, Pascal GJ et al (2024) Decorin suppresses tumor lymphangiogenesis: a mechanism to curtail cancer progression. Proc Natl Acad Sci 121:e2317760121. https:\/\/doi.org\/10.1073\/pnas.2317760121","DOI":"10.1073\/pnas.2317760121"},{"key":"10869_CR22","doi-asserted-by":"publisher","unstructured":"Nascimento EG do, de Carvalho GAF, da Jardim GP et al (2022) C, Epidemiologia do c\u00e2ncer de pr\u00f3stata no Brasil nos \u00faltimos 10 anos. Rev Sa\u00fade 13:48\u201352. https:\/\/doi.org\/10.21727\/rs.v13i2.2855","DOI":"10.21727\/rs.v13i2.2855"},{"key":"10869_CR23","doi-asserted-by":"crossref","unstructured":"Niland S, Riscanevo AX, Eble JA Matrix metalloproteinases shape the tumor microenvironment in cancer progression. https:\/\/www.mdpi.com\/1422-0067\/23\/1\/146. Accessed 17 Oct 2025","DOI":"10.3390\/ijms23010146"},{"key":"10869_CR24","doi-asserted-by":"publisher","first-page":"12276","DOI":"10.3390\/ijms222212276","volume":"22","author":"E Pach","year":"2021","unstructured":"Pach E, K\u00fcmper M, Fromme JE et al (2021) Extracellular matrix remodeling by fibroblast-MMP14 regulates melanoma growth. Int J Mol Sci 22:12276. https:\/\/doi.org\/10.3390\/ijms222212276","journal-title":"Int J Mol Sci"},{"key":"10869_CR25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00432-022-04274-w","volume":"149","author":"\u00c9R Pereira","year":"2023","unstructured":"Pereira \u00c9R, Pinheiro LCL, Francelino AL et al (2023) Tissue immunostaining of candidate prognostic proteins in metastatic and non-metastatic prostate cancer. J Cancer Res Clin Oncol 149:567\u2013577. https:\/\/doi.org\/10.1007\/s00432-022-04274-w","journal-title":"J Cancer Res Clin Oncol"},{"key":"10869_CR26","doi-asserted-by":"publisher","first-page":"114077","DOI":"10.1016\/j.yexcr.2024.114077","volume":"439","author":"LCL Pinheiro","year":"2024","unstructured":"Pinheiro LCL, Pupim ACE, Ahrens TM et al (2024) Deposition of collagen III and alterations in basement membrane integrity as candidate prognostic markers in prostate cancer. Exp Cell Res 439:114077. https:\/\/doi.org\/10.1016\/j.yexcr.2024.114077","journal-title":"Exp Cell Res"},{"key":"10869_CR27","doi-asserted-by":"publisher","first-page":"6924","DOI":"10.34119\/bjhrv4n2-238","volume":"4","author":"JP Ponte","year":"2021","unstructured":"Ponte JP, Cardoso AL, de Aires C CAM, et al (2021) Tratamento do c\u00e2ncer de pr\u00f3stata horm\u00f4nio refrat\u00e1rio atual e suas inova\u00e7\u00f5es: Revis\u00e3o de literatura \/ Treatment of current prostate hormone refractory cancer and its innovations: literature review. Brazilian J Health Rev 4:6924\u20136930. https:\/\/doi.org\/10.34119\/bjhrv4n2-238","journal-title":"Brazilian J Health Rev"},{"key":"10869_CR28","doi-asserted-by":"publisher","unstructured":"Rego RFNB, Barros RA, Pimenta LOS et al (2020) PERFIL CL\u00cdNICO EPIDEMIOL\u00d3GICO DA POPULA\u00c7\u00c3O ATENDIDA NUM PROGRAMA DE RASTREAMENTO DE C\u00c2NCER DE PR\u00d3STATA. Revista de Aten\u00e7\u00e3o \u00e0 Sa\u00fade 18 (65): 38-47. https:\/\/doi.org\/10.13037\/ras.vol18n65.6647","DOI":"10.13037\/ras.vol18n65.6647"},{"key":"10869_CR29","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3390\/biom10081199","volume":"10","author":"A Reszegi","year":"2020","unstructured":"Reszegi A, Horv\u00e1th Z, Kar\u00e1szi K et al (2020) The protective role of decorin in hepatic metastasis of colorectal carcinoma. Biomolecules 10:1199. https:\/\/doi.org\/10.3390\/biom10081199","journal-title":"Biomolecules"},{"key":"10869_CR30","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/nrc2229","volume":"7","author":"E Sahai","year":"2007","unstructured":"Sahai E (2007) Illuminating the metastatic process. Nat Rev Cancer 7:737\u2013749. https:\/\/doi.org\/10.1038\/nrc2229","journal-title":"Nat Rev Cancer"},{"key":"10869_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/biomedicines12010079","volume":"12","author":"I Samar\u017eija","year":"2024","unstructured":"Samar\u017eija I (2024) The potential of extracellular matrix- and integrin adhesion complex-related molecules for prostate cancer biomarker discovery. Biomedicines 12:79. https:\/\/doi.org\/10.3390\/biomedicines12010079","journal-title":"Biomedicines"},{"key":"10869_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.pathol.2019.05.001","volume":"51","author":"JR Srigley","year":"2019","unstructured":"Srigley JR, Delahunt B, Samaratunga H et al (2019) Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation. Pathology 51:463\u2013473. https:\/\/doi.org\/10.1016\/j.pathol.2019.05.001","journal-title":"Pathology"},{"key":"10869_CR34","doi-asserted-by":"publisher","first-page":"680136","DOI":"10.1155\/2013\/680136","volume":"2013","author":"AV Suhovskih","year":"2013","unstructured":"Suhovskih AV, Mostovich LA, Kunin IS et al (2013) Proteoglycan expression in normal human prostate tissue and prostate cancer. Int Sch Res Notices 2013:680136. https:\/\/doi.org\/10.1155\/2013\/680136","journal-title":"Int Sch Res Notices"},{"key":"10869_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality Worldwide for 36 Cancers in 185 countries. CA: A Cancer. J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"J Clin"},{"key":"10869_CR36","first-page":"5934","volume":"13","author":"B Tan","year":"2023","unstructured":"Tan B, Zheng X, Xie X et al (2023) MMP11 and MMP14 contribute to the interaction between castration-resistant prostate cancer and adipocytes. Am J Cancer Res 13:5934\u20135949","journal-title":"Am J Cancer Res"},{"key":"10869_CR37","doi-asserted-by":"publisher","unstructured":"Wang J-F, Gong Y-Q, He Y-H et al (2020) High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer. Eur Rev Med Pharmacol Sci 24 (12): 6605-6615. https:\/\/doi.org\/10.26355\/eurrev_202006_2166","DOI":"10.26355\/eurrev_202006_2166"},{"key":"10869_CR38","doi-asserted-by":"publisher","first-page":"14989","DOI":"10.18632\/aging.203060","volume":"13","author":"L Zhang","year":"2021","unstructured":"Zhang L, Liu C, Gao H et al (2021) Study on the expression profile and role of decorin in the progression of pancreatic cancer. Aging 13:14989\u201314998. https:\/\/doi.org\/10.18632\/aging.203060","journal-title":"Aging"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10869-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10869-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10869-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:48:52Z","timestamp":1786949332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10869-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10869"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10869-1","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"202"}}